Tabula Rasa HealthCare (Tabula Rasa HealthCare) EBIT : $-54.1 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare EBIT?

Tabula Rasa HealthCare's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $-8.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $-54.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tabula Rasa HealthCare's annualized ROC % for the quarter that ended in Jun. 2023 was -9.77%. Tabula Rasa HealthCare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -173.64%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Tabula Rasa HealthCare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -9.70%.

Tabula Rasa HealthCare EBIT Historical Data

The historical data trend for Tabula Rasa HealthCare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare EBIT Chart

Tabula Rasa HealthCare Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

-49.74

-32.65

-41.18

-42.74

-67.91

Tabula Rasa HealthCare Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBIT	Get a 7-Day Free Trial															-10.09	-23.17	-16.75	-5.70	-8.47

Competitive Comparison of Tabula Rasa HealthCare's EBIT

For the Health Information Services subindustry, Tabula Rasa HealthCare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tabula Rasa HealthCare's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tabula Rasa HealthCare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tabula Rasa HealthCare's EV-to-EBIT falls into.

Tabula Rasa HealthCare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.1 Mil.

Tabula Rasa HealthCare (NAS:TRHC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tabula Rasa HealthCare's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-22.728 * ( 1 - -1.38% )	/	( (235.471	+	236.11)	/ 2 )
=	-23.0416464	/	235.7905
=	-9.77 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	355.597	-	63.507	-	( 67.19	-	max(0, 86.334	-	142.953	+	67.19	))
=	235.471

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	355.937	-	66.837	-	( 62.811	-	max(0, 93.691	-	146.681	+	62.811	))
=	236.11

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Tabula Rasa HealthCare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-33.864	/	( ( (19.487 + max(-43.914, 0))	+	(19.518 + max(-45.715, 0)) )	/	2 )
=	-33.864	/	( ( 19.487	+	19.518 )	/	2 )
=	-33.864	/	19.5025
=	-173.64 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(19.143	+	7.39	+	13.089)	-	(63.507	+	3.48	+	16.549)
=	-43.914

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(18.61	+	8.659	+	17.725)	-	(66.837	+	3.215	+	20.657)
=	-45.715

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Tabula Rasa HealthCare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	-54.086	/	557.619
	=	-9.70 %

Tabula Rasa HealthCare EBIT Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057

Website

https://www.trhc.com

Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.

Executives

Michael Anthony Bruno	officer: CHIEF ACCOUNTING OFFICER	1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier	director, 10 percent owner	C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p.	director, 10 percent owner	MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p.	director, 10 percent owner	ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc	director, 10 percent owner	ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii	officer: Chief Legal Officer, Secretary	7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro	officer: CHIEF FINANCIAL OFFICER	C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell	director	C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell	director	110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz	director	430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling	director	228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh	officer: Chief Operating Officer	228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall	director
Andrea Carolan Speers	officer: Chief Accounting Officer	228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams	officer: Chief Financial Officer	228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057